News

November 2018

Winterlight research accepted to NeurIPS 2018 workshops

Two of our research papers were accepted and will be presented at NeurIPS (the conference previously known as NIPS) workshops next week in Montreal. NeurIPS is the leading machine learning conference - tickets sold out in 20 minutes.

Read Read More
October 2018

Winterlight technology shows positive results of treatment in Phase 1 study of COR388 in Alzheimer’s disease

No significant improvements were observed in Mini Mental State Examination (MMSE) scores or CANTAB measures of cognition between treatment (COR388) and placebo groups. In contrast, Winterlight’s cognitive assessment showed statistically significant improvements from baseline to endpoint in the treatment group, with no such differences seen in the placebo group.

Read Read More
January 2018

Winterlight Labs is featured on CTV News, discussing its partnership with Revera

Winterlight will be piloting its speech-based cognitive assessment at one of Revera's senior care homes in Toronto with 50 participants over a 6 month period. This pilot was funded via the Ontario Centres of Excellence (OCE) Health Technology Fund (HTF).

Read Read More
January 2018

Winterlight Labs participates in a J&J feasibility study

The research will evaluate Winterlight's proprietary technology for analyzing voice samples obtained from Janssen Research & Development's ongoing clinical trials in Alzheimer's and neurodegenerative diseases.

Read Read More
August 2017

Winterlight Labs secures additional seed funding ($1,000,000) from American investors

Winterlight Labs has closed $1,000,000 in additional seed funding from Grey Sky Venture Partners (GSVP), based on Bellevue Washington. In total, Winterlight Labs has raised $1.5 million.

Read Read More
January 2017

Winterlight Labs' Co-founder Liam Kaufman interviewed on Fairchild TV’s Timeline Magazine

Liam Kaufman describes how the technology works and gives a demonstration of the app. Liam Kaufman on Fairchild TV’s Timeline Magazine.

Read Read More
January 2017

Winterlight Labs’ Frank Rudzicz quoted in Wired Magazine

Winterlight Co-founder Frank Rudzicz explains how the technology works in Wired Magazine.

Read Read More
January 2017

Winterlight Labs secures seed funding to commercialize speech-based detection of cognitive impairments

Winterlight Labs closed the first tranche of $500,000 in seed funding from Novatio Ventures, an early stage life sciences investment firm.

Read Read More
July 2016

Canadian Technology that Uses Speech to Track Alzheimer’s Captures First Prize at AGE-WELL Pitch Competition

Winterlight Labs has won the AGE-WELL Pitch Competition: Technology to Support People with Dementia. Ten teams from Canada and around the world competed in the AGE-WELL Pitch Competition.

Read Read More
July 2016

Winterlight Labs “Graduates” from the Rotman Creative Destruction Lab

Winterlight Labs has graduated from the Rotman Business School’s Creative Destruction Lab (CDL). The CDL works with startups that employ innovations in technology and business models that promise a chance of delivering massive improvements to economic productivity and human welfare.

Read Read More
December 2015

Winterlight Labs Co-founders publish ground-breaking research on dementia and Alzheimers Disease detection using natural language

Winterlight co-founders Katie Fraser, Frank Rudzicz, and Winterlight scientific advisor Jed Meltzer have discovered how to diagnose Alzheimer's disease with more than 82 per cent accuracy by evaluating the interplay between four linguistic factors.

Read Read More